Furthermore, the analysis verified our hypothesis that the enhanced IL-17 signaling response increases CD8+ T cell infiltration in breast cancer, which provides a possible explanation for the high CD8+ T cell infiltration level in ER-negative breast cancer or TNBC. The gene discussed is IL17A; the disease is breast carcinoma.